Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Orgenesis
Orgenesis
Activities:
Research & Development
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
Orgenesis and Theracell collaboration designated priority investment in Greece
As a result of this designation, the venture will be inducted into the country’s fast-track licensing and approval process
Research & Development
Orgenesis announces collaboration with Tel Aviv Medical Center
The collaboration aims to advance point-of-care development and commercialisation of cell and gene and therapies
Finance
Orgenesis to collaborate with Savicell on ImmunoBiopsy platform
The collaboration aims to develop and validate diagnostic kits for enhanced quality control (QC) and monitoring purposes to be used by Orgenesis for CGT applications
Research & Development
Orgenesis to trial Tissue Genesis Icellator tech for cell recovery
The trial is supported by the National Stem Cell Foundation and an OREF clinical research grant in cellular therapy in honour of James Urbaniak, MD
Drug Delivery
Orgenesis signs joint venture with Cure Therapeutics
The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies
Pharmaceutical
Orgenesis launches cell-based vaccine platform targeting SARS-CoV-2
US biotech has created a cell-based vaccine platform targeting solid tumours for use against viral diseases
Finance
Orgenesis acquires cell therapy manufacturer MaSTherCell
Acquisition to accelerate type 1 diabetes therapeutic into clinical trials and diversify future business model and product offering
Subscribe now